کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5621939 1579194 2017 5 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Full Length ArticleImpact of thrombophilia screening on venous thromboembolism management practices
ترجمه فارسی عنوان
طول کامل ماده بررسی تاثیر ترومبوفیلی بر شیوه های مدیریت ترومبوآمبولی وریدی
موضوعات مرتبط
علوم پزشکی و سلامت پزشکی و دندانپزشکی کاردیولوژی و پزشکی قلب و عروق
چکیده انگلیسی


- Few patients continue anticoagulation based on thrombophilia testing.
- Anticoagulation decreases the risk of VTE recurrence regardless of thrombophilia.
- Thrombophilia testing may be better constrained to patients at low risk for recurrence.

BackgroundIt is unclear whether thrombophilia testing provides any further information on risk of recurrence or guidance in management of patients with a first episode of idiopathic venous thromboembolism (VTE). Furthermore, after the introduction to clinical practice of clinical prediction rules, thrombophilia screening could be less relevant in anticoagulation decision making. We assessed the potential impact of thrombophilia screening on the decision of maintaining anticoagulation beyond the initially planned anticoagulation period in patients with an unprovoked VTE, before and after the introduction of a clinical prediction rule into practice.Patients/MethodsWe conducted a single center, retrospective cohort study of consecutive patients with a diagnosis of unprovoked VTE, including a study period of 12 years. Two groups were compared, before and after 2008.ResultsWe included 1033 patients of which 85.2% were tested for thrombophilia and 26.2% were identified with any thrombophilia. A similar proportion of patients continued on anticoagulation after 6 months (54.1% vs 57.1%, respectively). The proportion of patients continuing anticoagulation based on the thrombophilia screen remained small (13.9% vs 12.7%, respectively). Continuing anticoagulation beyond the initial period planned resulted in a 75% risk reduction in VTE recurrence, independent of the presence of thrombophilia (HR 0.25, 95% CI 0.12-0.55; P < 0.001).ConclusionsThrombophilia screening continues to have little relevance in clinical decision making for anticoagulation. Prolonging anticoagulation beyond 6 months in an at-risk population decreased the risk of VTE recurrence regardless of their thrombophilia status.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Thrombosis Research - Volume 149, January 2017, Pages 76-80
نویسندگان
, , , , , ,